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Summary
In the early Drosophila embryo, asymmetric distribu-
tion of transcription factors, established as a conse-
quence of translational control of their maternally
derived mRNAs, initiates pattern formation [1–4]. For
instance, translation of the uniformly distributed
maternal hunchback (hb) mRNA is inhibited at the pos-
terior to form an anterior-to-posterior protein concen-
tration gradient along the longitudinal axis [5, 6]. Inhi-
bition of hb mRNA translation requires an mRNP
complex (the NRE complex), which consists of Nanos
(Nos), Pumilio (Pum), and Brain tumor (Brat) proteins,
and the Nos responsive element (NRE) present in the 30
UTR of hb mRNA [7–9]. The identity of the mRNA 50 ef-
fector protein that is responsible for this translational
inhibition remained elusive. Here we show that d4EHP,
a cap binding protein that represses caudal (cad)
mRNA translation [10], also inhibits hb mRNA transla-
tion by interacting simultaneously with the mRNA 50
cap structure (m7GpppN, where N is any nucleotide)
[11] and Brat. Thus, by regulating Cad and Hb expres-
sion, d4EHP plays a key role in establishing anterior-
posterior axis polarity in the Drosophila embryo.
Results and Discussion
Transcription is globally repressed in the rapidly dividing
nuclei of early Drosophila embryos, and therefore gene
expression is largely regulated by translational control
of maternally provided mRNAs [1]. Translation is often
regulated at initiation, which occurs in multiple steps
starting with the recruitment of the 40S ribosomal sub-
unit to the 50 end of an mRNA and resulting in the correct
positioning of the 80S ribosome at the initiation codon
[12, 13]. Recognition of the cap structure by eIF4F (com-
posed of three subunits, eIF4E, eIF4A, and eIF4G) is an
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racts both with eIF4E and the poly(A) binding protein
(PABP), thus circularizing the mRNA, which in turn is be-
lieved to promote reinitiation [2, 14, 15]. Consistent with
their importance, eIF4E and PABP have emerged as
major targets of translational regulatory mechanisms
mediated by such modulator proteins as 4E-BPs and
Paip2 [15–17].
Embryonic development in many metazoans requires
the activity of various maternal determinants called mor-
phogens, whose spatial and temporal expression is
tightly regulated [1–4]. In Drosophila, local morphogen
concentrations are important for the establishment of
polarity and subsequent organization of both the antero-
posterior and dorsoventral axes of the embryo. A key
morphogen for anteroposterior patterning is the tran-
scription factor Hunchback (Hb); when maternal Hb is al-
lowed to accumulate inappropriately, posterior segmen-
tation is blocked [8, 18, 19]. Two modes of translational
control have been proposed for the establishment of the
maternal Hb gradient: translational silencing via deade-
nylation [20] and inhibition at the initiation step in a cap-
dependent manner [9].
d4EHP, an eIF4E-like cap binding protein that does
not interact with deIF4G and d4E-BP, inhibits the trans-
lation of cad mRNA by interacting simultaneously with
the cap and Bicoid (Bcd) [10]. While many embryos
(w41%) produced by females homozygous for the
d4EHPCP53 mutation showed anterior patterning defects
consistent with mislocalized Cad, some (w7%) also ex-
hibited patterning defects such as missing abdominal
segments [10] that cannot be readily explained by ec-
topic Cad expression. Since inhibition of hb mRNA
translation has been linked in one study to the cap struc-
ture [9], and since these additional phenotypes could be
consistent with inappropriate regulation of Hb, we in-
vestigated the role of d4EHP in Hb expression. Embryos
(0–2 hr) from females homozygous for the d4EHPCP53
mutation [10] were collected and immunostained with
Hb antibody. DNA was stained with DAPI to highlight
the nuclei (Figures 1A–1E). For simplicity, embryos will
subsequently be referred to by their maternal genotype.
To evaluate the extent of the Hb gradient, we measured
its signal intensity at 38–50 locations along the anterior-
posterior axes of 6–16 embryos of each genotype. We
corrected the values for overall signal intensity and
then normalized the data for embryo length (EL, anterior
pole = 0%, posterior pole = 100%, see Experimental
Procedures). The normalized values were plotted and
average intensity values were calculated to obtain an av-
erage trend (see Experimental Procedures; Figures 1F
and 1G). We observed that in OreR embryos, Hb signal
intensity drops steeply in the middle of the embryo
(Figure 1A) and reaches 50% maximum intensity at
48% EL (Figure 1F). In d4EHPCP53 embryos, the Hb ex-
pression domain extended substantially farther toward
the posterior (Figure 1B) and signal intensity remained
at approximately 50% of the maximum throughout the
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2036Figure 1. d4EHP Interaction with the Cap Structure Is Required for hb Translation Inhibition
Hb immunostaining appears red, and DAPI (blue) was used to stain nuclei.
(A–E) Confocal images are focused on the embryo surface to illustrate the Hb gradient, and therefore not all nuclei are in focus.
(A) OreR embryos display normal Hb gradient.
(B) d4EHPCP53 mutant embryos show extended Hb expression into the posterior half.
(C) Expression of d4EHPWT transgene in the d4EHPCP53 mutant background rescues the mutant phenotype.
(D) Embryos derived from females expressing d4EHPW114A fail to fully repress posterior Hb expression.
(E) Embryos derived from females expressing d4EHPW85F show wild-type Hb distribution pattern.
(F) Plot of normalized Hb intensities measured from wt (red) and d4EHPCP53 (blue) embryos. Calculated average intensity values were used to
generate average trends (thick lines). The low-intensity values at the anterior pole (near 0% EL) derive from focal deformation of the image
(the focus was on the embryo surface).
(G) Plot of normalized Hb intensities measured from d4EHPCP53 embryos rescued with different d4EHP transgenes (d4EHPwt black, d4EHPW114A
green, d4EHPW85F orange). The average trends were calculated as in (F). The posterior pole is indicated as 100% (A–E) or 1 (F, G). Orientation of
embryos is anterior left and dorsal up.region between 50% and 75% EL (Figure 1F). Normal Hb
distribution was restored to d4EHPCP53 mutant embryos
by transgene-derived expression of wild-type d4EHP
(d4EHPwt, Figures 1C and 1G), but not by expression
of a mutant form of d4EHP (d4EHPW114A), which is un-
able to bind the cap structure (Figures 1D and 1G). Ex-
pression of another form of d4EHP (d4EHPW85F), which
cannot bind Bcd, fully rescued the defective Hb gradient
(Figures 1E and 1G). The expression levels of the wild-
type and mutantd4EHP transgenes are essentially equal
[10]. Distributions of Nos, Pum, and Brat were unaf-
fected in d4EHPCP53 mutant embryos (Figure S1 in the
Supplemental Data available online). Taken together,
these data demonstrate that d4EHP plays a key role in
establishing the posterior boundary of Hb expression
in a manner that requires its cap binding activity but
not an association with Bcd.
We reasoned that Brat might be a candidate partner
protein for d4EHP, since both are relevant for hbregulation. Thus, we investigated whether d4EHP and
Brat physically interact in vivo. Extracts prepared from
0 to 2 hr Oregon-R (OreR) embryos were treated with RN-
ase and used to examine the interaction between Brat
and d4EHP. Western blotting analysis with antibodies
against d4EHP [10] and Brat (Figure S2) demonstrates
that, while anti-d4EHP coimmunoprecipitated endoge-
nous Brat (Figure 2A; lane 3), preimmune serum did
not (lane 2). To further demonstrate the specificity of
this interaction, HA-tagged deIF4EI and the RNA-bind-
ing protein La (negative controls) were transfected in
HEK293 cells along with FLAG-tagged full-length Brat.
While FLAG antibody immunoprecipitated wild-type
HA-d4EHP together with FLAG-Brat (Figure 2B, lane 2),
deIF4EI and La failed to coimmunoprecipitate (lanes 1
and 3). Similarly, other RNA-binding proteins such as
hnRNP U and HuR, and a d4EHP mutant (W173A), in
which a tryptophan residue that is part of the hydro-
phobic core and thus affects protein folding is replaced,
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2037Figure 2. Characterization of the d4EHP:Brat Interaction
(A) d4EHP interacts with Brat in vivo.OreR embryo (0–2 hr) extract (lane 1) was immunoprecipitated with preimmune (lane 2) or anti-d4EHP (lane 3)
antisera. Eluted proteins were analyzed by western blotting for the presence of Brat (top) and d4EHP (bottom).
(B) d4EHP interacts specifically with Brat. FLAG-tagged Brat was transfected in HEK293 cells together with HA-tagged deIF4EI, d4EHP, or La.
Proteins from cell extracts were immunoprecipitated (IP) with an FLAG antibody and analyzed by western blotting with antibodies against FLAG
and HA.
(C) The d4EHP:Brat interaction is mediated by the third dorsal a helix of d4EHP. FLAG-tagged Brat wild-type NHL domain was transfected in
HEK293 cells together with HA-tagged deIF4EI, d4EHP, or d4EHP/deIF4EI chimeras.
(B and C) Proteins from cell extracts were immunoprecipitated (IP) with a FLAG antibody and analyzed by western blotting with antibodies
against FLAG and HA.
(D) The d4EHPdeIF4EI helix 3 mutant interacts with the cap. HEK293 cell extracts (top) containing transfected HA-tagged wild-type d4EHP (lane 1),
d4EHPW114A (lane 2), and d4EHPdeIF4EI helix 3 (lane 3) were incubated with m7GTP-Sepharose, and the eluate was analyzed by western blotting
(bottom).
(E) d4EHP interacts with the Brat C-terminal NHL domain. FLAG-tagged Brat wild-type or DNHL mutant were transfected in HEK293 cells with
HA-tagged d4EHP, and cell extracts were subjected to western blotting (top). Cell extracts were immunoprecipitated with a FLAG antibody and
analyzed by western blotting (bottom).
(F) Ribbon diagrams of the Brat NHL domain [21]. The positions of select surface residues are indicated.
(G) Interaction of Brat mutants with d4EHP. FLAG-tagged wild-type (lane 2) or mutants of the Brat NHL domain (lanes 3–7) were transfected in
HEK293 cells together with HA-tagged d4EHP, and cell extracts were subjected to western blotting (top). Cell extracts were immunoprecipitated
with a FLAG antibody and eluted proteins were analyzed for the presence of FLAG-Brat and HA-d4EHP by western blotting (bottom). All proteins
shown migrated at the positions expected from their molecular mass, as compared with molecular weight markers run on the same gels (data not
shown).
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2038Figure 3. d4EHP Interacts with the NRE
Complex In Vitro
Samples containing in vitro translated HA-
tagged d4EHP and purified components of
the NRE complex were used to perform an
in vitro GST pull-down experiment. Eluted
proteins were analyzed for the presence of
GST-Pum RNAB, His6-Nos C-term, His6-Brat
NHL domain, and HA-d4EHP by western blot-
ting. All proteins shown migrated at the posi-
tions expected from their molecular mass, as
compared with molecular weight markers run
on the same gels (data not shown).also failed to interact with Brat (data not shown), demon-
strating that Brat interacts specifically with d4EHP.
Since we used a cell transfection system to assay for the
d4EHP:Brat interaction, it is possible that other bridging
proteins are required for the d4EHP-Brat association.
To identify the Brat-interacting domain of d4EHP, we
first mutated a number of individual residues located
on its convex dorsal surface and tested for coimmuno-
precipitation with Brat. From this work, we were unable
to identify a point mutant of d4EHP that abrogated the in-
teraction (data not shown). As an alternative approach,
we created chimeric proteins in which different domains
of d4EHP were replaced with their counterparts from de-
IF4EI, taking advantage of our knowledge that, unlike
d4EHP, deIF4EI does not interact with Brat (Figure 2C,
lane 1). We produced three mutant forms of d4EHP,
with each one of its three dorsal a helices [21] replaced
with that of deIF4EI. We found that while helix 1 and 2 mu-
tants failed to disrupt binding to Brat (Figure 2C, lanes 3
and 4), replacement of d4EHP helix 3 (residues 179–194)
significantly reduced the interaction with Brat (Figure 2C,
lane 5). Consistent with these observations, a helix 3 is
the most divergent between d4EHP and deIF4EI [10].
The overall structure of d4EHP is not affected by the re-
placement of helix 3 with its deIF4EI counterpart, since
the chimeric protein still binds to the cap (Figure 2D,
lane 3). Thus, our data demonstrate that Brat interacts
with d4EHP on its convex dorsal surface and that this in-
teraction is mediated by the third a helix of d4EHP.
A C-terminal domain of Brat termed the NHL domain is
both necessary and sufficient to inhibit hb mRNA trans-
lation [7]. The NHL domain contains two large surfaces
(defined as top and bottom) that can support protein-
protein interactions [22]. While the top surface of the
NHL domain binds to Pum and Nos, the bottom surface
does not interact with any known protein [7, 22].
Although the Brat NHL domain contains an amino acid
sequence that conforms to the YxxxxxxLF d4EHPbinding motif [10], the d4EHP:Brat interaction does not
require this motif, since a Brat deletion mutant that lacks
it can still interact with both d4EHP and the d4EHP W85F
mutant (Figure S3). This sequence is most probably
masked from interaction with d4EHP because it is
located in the hydrophobic core of the NHL domain
[22]. To determine whether the d4EHP:Brat interaction
requires the NHL domain, a Brat mutant that lacks the
domain (Brat DNHL) was engineered and used in a
coimmunoprecipitation experiment (Figure 2E). While
wild-type Brat was readily coimmunoprecipitated with
d4EHP, the Brat DNHL mutant was not (compare lanes 1
and 2). Thus, we conclude that the NHL domain is the
site of d4EHP interaction. To further characterize this in-
teraction, point mutations were designed to replace res-
idues on the two surfaces of the NHL domain (Figure 2F),
and the mutant proteins were tested for their ability to in-
teract with d4EHP. Mutation of a top surface residue that
affects Brat interaction with Pum (G774A; Figure 2G,
lane 3) [7] did not affect the d4EHP:Brat interaction.
However, when residues on the bottom surface were
mutated, the d4EHP:Brat interaction was either signifi-
cantly reduced (G860D and KE809/810AA; lanes 4 and
5) or abrogated (R837D and K882E; lanes 6 and 7; note
that the charge differences caused R837D and K882E
mutant proteins to migrate slower in the gel). Impor-
tantly, the Brat NHL R837D mutant can assemble into an
NRE complex (see below; Figure 3, lane 4), demonstrat-
ing that this mutation specifically affects the d4EHP
interaction and not the interactions with Pum and Nos.
Brat inhibits hb mRNA translation by interacting with
the NRE complex [7]. Since d4EHP interacts physically
with Brat, we asked whether d4EHP can be copurified
with the NRE complex in vitro. Incubation of recombi-
nant components of the NRE complex (Brat, Pum, Nos,
and NRE) together with HA-tagged d4EHP resulted in
the retention of d4EHP on glutathione-Sepharose beads
through the GST-Pum RNAB fusion protein (Figure 3,
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2039Figure 4. Functional Analysis of brat Mutants in Transgenic Drosophila Embryos
(A and B) Embryos derived from homozygous bratfs1 females show a shift of the Hb expression boundary toward the posterior.
(C and D) Embryos derived from females expressing bratWT in the bratfs1 mutant background show wild-type Hb distribution pattern.
(E–H) Embryos derived from females expressing mutant bratR837D and bratK882E genes (unable to bind d4EHP) exhibit ectopic Hb expression.
(B, D, F, and H) Embryos stained for both Hb and Nos proteins with the same secondary antibody, the latter serving as an internal control for
staining intensity. The anterior tip is indicated as 0%. Orientation of embryos is anterior left and dorsal up.
(I) Western blot analysis of embryo extracts with anti-Brat or anti-a-tubulin as a loading control. Two to three independent transgenic lines were
examined for each experiment, with similar results.lane 2). The association of Brat with d4EHP was depen-
dent on the ability of d4EHP to bind to Brat, since addi-
tion of Pum/Nos/NRE alone or in combination with the
Brat R837D mutant failed to capture it (lanes 3 and 4).
Thus, by interacting with Brat, d4EHP can associate
with the NRE complex.
To investigate the biological significance of the
d4EHP:Brat interaction, we studied the effects of Brat
mutants, which are defective for d4EHP binding, in Dro-
sophila embryos. As previously shown [7],bratfs1 mutant
embryos exhibit a significant expansion of the Hb ex-
pression domain toward the posterior (Figures 4A and
4B) and display severe abdominal segmentation defects
(Table 1). When a bratWT transgene is expressed in the
bratfs1 mutant background, normal Hb distribution (Fig-
ures 4C and 4D) and a wild-type segmentation pattern is
restored [7] (Table 1). To investigate whether interaction
with d4EHP is essential for the function of Brat in embry-
onic patterning, we introduced transgenes encoding
mutant forms of Brat that affect the d4EHP:Brat inter-
action (bratR837D and bratK882E) into the bratfs1 mutantbackground. Despite being expressed at levels similar
to the bratWT transgene (Figure 4I), these mutant forms
fail to fully rescue the normal Hb gradient (Figures 4E–
4H) and, importantly, do not fully rescue the bratfs1
mutant phenotype (Table 1). Taken together, our data
strongly argue that the d4EHP:Brat interaction contrib-
utes significantly to hb regulation.
We have demonstrated here that through its inter-
action with Brat, d4EHP defines and sharpens the
Table 1. Abdominal Segmentation Defects in Brat Mutant Embryos
Number of Abdominal Segments
0 1 2 3 4 5 6 7 8
Bratfs1/Df(2L)TE37C-7 2 10 62 20 5 1
Bratfs1/Df(2L)TE37C-7; BratWT 100
Bratfs1/Df(2L)TE37C-7; BratR837D 7 24 39 30
Bratfs1/Df(2L)TE37C-7; BratK882E 20 41 39
Each entry is the percentage of embryos derived from females of the
indicated genotype (left) bearing the indicated number of abdominal
segments (above). 70 to 100 embryos were scored in each case.
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pomorphic d4EHPCP53 phenotype, its activity appears
most relevant to hb regulation in the region of the em-
bryo from 50% to 75% EL, although it is possible that
a null d4EHP allele would have more drastic effects.
The d4EHP:Brat interaction is mediated via residues
on the bottom surface of the Brat NHL domain (Figures
2F and 2G). Thus, as in the model we established for
cad [10], a simultaneous interaction of d4EHP with the
cap and Brat results in mRNA circularization and ren-
ders hb translationally inactive. Since the interaction be-
tween Brat and d4EHP does not involve the 4EHP bind-
ing motif we previously described (YxxxxxxLF), it is
possible that d4EHP interacts with Brat through a bridg-
ing protein.
Our data support a model for the requirement for the 50
cap structure in regulation of endogenous hb mRNA.
This is consistent with an earlier study that assessed
translation of NRE-containing mRNAs after injection
into Drosophila embryos and concluded that the cap
structure is functionally significant [9]. In contrast, an-
other study reported that Nos and Pum repressed the
expression of an engineered transgene containing an in-
ternal ribosome entry site (IRES) and a hairpin loop de-
signed to block cap-dependent translation [23]. These
results were used to conclude that hb translational re-
pression is cap independent. However, the phenotypic
assay used in that study was indirect and the observed
results could also be caused by RNA destabilization.
Furthermore, Nos-dependent deadenylation was also
shown to be important in establishing the Hb gradient
[20]. It is difficult to reconcile all these data without con-
cluding that multiple distinct posttranscriptional mecha-
nisms regulate Hb expression, including two that require
Nos. The novel d4EHP-dependent mechanism we de-
fined appears important for repressing hb in more cen-
tral regions of the embryo, while cap-independent regu-
lation involving deadenylation of hb mRNA may
predominate in more posterior regions of the embryo.
We note that mutant forms of Brat that are abrogated
for d4EHP interaction retain substantial (but not com-
plete) activity in repressing hb, suggesting some redun-
dancy between these two mechanisms. Analogous
overlapping translational control mechanisms have re-
cently been reported for Bruno, which represses Oskar
(Osk) expression both through cap-dependent transla-
tional regulation and through packaging osk mRNA
into translationally silent RNP complexes [24].
Our identification of a common inhibitory mechanism
that regulates cad and hb mRNA translation simplifies
our understanding of how the anterior-posterior axis is
organized during early Drosophila embryogenesis. By
regulating two classical maternal morphogenetic gradi-
ents, d4EHP plays a critical role in early Drosophila em-
bryonic development. It is noteworthy that d4EHP is re-
cruited to these mRNAs through different RNA binding
proteins that presumably recognize different sequence
elements. In the case of cad, d4EHP becomes associ-
ated by binding directly to Bcd, which in turn recognizes
a defined 30UTR element, the BBR [25, 26]. In the case of
hb, Bcd binding is not involved in d4EHP recruitment
and no element similar to the BBR is present. It remains
uncertain whether the interaction between d4EHP and
Brat is direct or indirect; because d4EHP and Brat areboth uniformly distributed in early embryos [7, 10], a non-
uniformly distributed bridging protein mediating this in-
teraction may be the basis of the spatially restricted re-
quirement for d4EHP in hb repression. Since d4EHP and
some of its interacting partners are evolutionarily con-
served in higher eukaryotes and because cap-depen-
dent translation regulation plays such an important
role in eukaryotic gene expression [16], we predict that
4EHP-dependent translational inhibitory mechanisms
are widespread throughout the animal kingdom.
Experimental Procedures
Plasmids
Cloning of d4EHP was previously described [10]. Brat cDNA
(RE16276; Research Genetics) was obtained from the Berkeley Dro-
sophila Genome Project [27]. All constructs reported herein were
produced with the polymerase chain reaction (PCR). For brat, PCR-
amplified wild-type and mutant cDNAs were introduced into the
pcDNA3-N-term-FLAG vector via EcoRV/NotI sites. For recombinant
protein expression, Brat NHL domain and Nos C-term domain (Nos
C-term) were subcloned into the pProEx-His vector by means of
SalI/NotI and EcoRI/XhoI sites, respectively, and Pum RNA binding
domain (Pum RNAB) into the pGEX 6p-1 vector by means of EcoRI/
SalI sites. NRE from hbmRNA, flanked by XbaI sites, was introduced
into the 30 UTR of pcDNA3-rLuc-DApaI reporter vector. To create
pCaSpeR4-nos promoter-Bratwild-type and mutant rescue vectors,
Brat constructs were inserted into the pKS-nos promoter vector by
means of NheI/NotI sites. Subsequently, a Kpn1/NotI cassette from
pKS-nos promoter-Brat wild-type and mutant vectors were trans-
ferred into the pCaSpeR4 vector. All inserts were fully sequenced.
Recombinant Protein Purification
E. coli BL21(DE3) transformed with the pProEx-Brat NHL domain,
pProEx-Nos C-term, and pGEX-Pum RNAB constructs were used to
produce His-Brat NHL domain, His-Nos C-term, and GST-Pum RNAB
fusion proteinsaspreviouslydescribed[10]. TALONMetalAffinity resin
(BD Bioscience) and glutathione Sepharose 4B resin (Amersham
Pharmacia) were used according to the manufacturers’ instructions.
Brat Antibody and Western Blotting Analysis
A Brat antibody (#3187) was raised in a New Zealand White rabbit in-
jected with recombinant His-Brat NHL domain protein and used for
western blotting (1:3000). Cell culture, coimmunoprecipitation, and
western blotting were performed as previously described [10].
Transgenic Rescue Experiment
Transgenic flies were generated by P element-mediated germline
transformation of yw recipients with pCaSpeR-nos promoter-Brat
wild-type and mutant rescue vectors. Transformed brat lines were
crossed to the bratfs1 mutant and tested for the rescue of mutant
phenotypes. pUASp-d4EHP transgenic lines [10] and antibody
staining were performed as previously described [28]. Hb and Nos,
Pum, and Brat immunostainings were visualized with Alexa Fluor
546 goat anti-rat IgG secondary and Alexa Fluor 488 goat anti-rabbit
IgG secondary, respectively (1:500; Molecular Probes) with a confo-
cal laser scanning microscope. Embryo images were analyzed for
Hb gradient with Zeiss LSM data acquisition software.
In Vitro Transcription/Translation and Binding Assay
pcDNA3-3HA-d4EHP [10] and pcDNA3-rLuc-DApaI-NRE vectors
were linearized with ApaI and transcribed with T7 RNA polymerase
(MBI). Nuclease-treated rabbit reticulocyte lysate (Promega) was in-
cubated for 1 hr at 30C with 300 ng of HA-d4EHP mRNA. Subse-
quently, the extract was supplemented with components of the
NRE complex, and the experiments of Figure 4 were performed as
previously described [7, 29].
Image Analyses, Immunofluorescence Quantitation, and Data
Analyses
0- to 2-hour-old embryos were immunostained with anti-Hb
(1:10,000, a gift of P. Macdonald) and Alexa Fluor 546-conjugated
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DAPI. Images were captured with a Zeiss LSM510 confocal micro-
scope. Quantitation of the fluorescence intensity was performed
with Openlab (Improvision) by recording the intensity values within
a nucleus-sized area sliding along the anterior-posterior axis. Multi-
ple embryos (6–16) for each genotype were measured at 38–50 po-
sitions along the anterior-posterior axis for a total of more than
3000 data points. For each embryo, length was normalized (0% = an-
terior pole, 100% = posterior pole), and measured intensities were
normalized by subtracting the intensity recorded at the posterior
pole and dividing this value by the maximum intensity measured
within the same embryo. Individual data points could have values
below zero if the local signal intensity was less than that at the pos-
terior pole. To generate the average curve, the data points for each
genotype were grouped in 38 bins (corresponding to the smallest
sample set). For each bin, values were averaged and the resulting
38 points constitute the average curve.
Supplemental Data
Three Supplemental Figures can be found with this article online
at http://www.current-biology.com/cgi/content/full/16/20/2035/
DC1/.
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